NovoCure Ltd — Director's Dealing 2017

Sep 27, 2017

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Novocure Ltd (NVCR)
CIK: 0001645113
Period of Report: 2017-09-25

Reporting Person: Danziger Asaf (Director, Chief Executive Officer)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2017-09-25	Ordinary Shares	S	900	$22.05	Disposed	774190	Direct

Footnotes

F1: These shares were sold pursuant to a Rule 10b5-1 trading plan adopted by Mr. Danziger.